Literature DB >> 7972745

Bronchiectasis: functional significance of areas of decreased attenuation at expiratory CT.

D M Hansell1, A U Wells, M B Rubens, P J Cole.   

Abstract

PURPOSE: To characterize areas of decreased attenuation on expiratory computed tomographic (CT) scans in patients with bronchiectasis.
MATERIALS AND METHODS: CT scans were obtained at full inspiration and end expiration in 70 patients with chronic purulent sputum production. Inspiratory scans were scored at a lobar level for the extent of bronchiectasis, and inspiratory and expiratory scans were scored for the presence and extent of areas of decreased attenuation. Total lobar observations were analyzed (n = 840).
RESULTS: Bronchiectasis was identified in 434 of 840 lobar observations. The total decreased attenuation score was related to extent of bronchiectasis (r = .49; P < .001), independent of functional indexes. Negative correlations were found between forced expiratory volume in 1 second (FEV1) and total decreased attenuation score (P < .002) and FEV1 to forced vital capacity ratio (P < .004) but not with indexes of gas transfer.
CONCLUSION: Areas of decreased attenuation on expiratory CT scans are common in severe bronchiectasis. Such areas in lobes without overt bronchiectasis suggest that small airways disease may precede the development of bronchiectasis.

Entities:  

Mesh:

Year:  1994        PMID: 7972745     DOI: 10.1148/radiology.193.2.7972745

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  23 in total

1.  Computerized methods for determining respiratory phase on dynamic chest radiographs obtained by a dynamic flat-panel detector (FPD) system.

Authors:  Rie Tanaka; Shigeru Sanada; Takeshi Kobayashi; Masayuki Suzuki; Takeshi Matsui; Osamu Matsui
Journal:  J Digit Imaging       Date:  2006-03       Impact factor: 4.056

2.  Detectability of regional lung ventilation with flat-panel detector-based dynamic radiography.

Authors:  Rie Tanaka; Shigeru Sanada; Nobuo Okazaki; Takeshi Kobayashi; Masayuki Suzuki; Takeshi Matsui; Osamu Matsui
Journal:  J Digit Imaging       Date:  2008-03       Impact factor: 4.056

Review 3.  Computed tomography of the airways.

Authors:  S A Worthy; C D Flower
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

4.  Abnormalities of the airways and lung parenchyma in asthmatics: CT observations in 50 patients and inter- and intraobserver variability.

Authors:  P Grenier; I Mourey-Gerosa; K Benali; M W Brauner; A N Leung; S Lenoir; M P Cordeau; B Mazoyer
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

5.  Respiratory Complications in Patients with Hyper IgM Syndrome.

Authors:  Bobak Moazzami; Reza Yazdani; Gholamreza Azizi; Fatemeh Kiaei; Mitra Tafakori; Mohammadreza Modaresi; Rohola Shirzadi; Seyed Alireza Mahdaviani; Mahsa Sohani; Hassan Abolhassani; Asghar Aghamohammadi
Journal:  J Clin Immunol       Date:  2019-06-11       Impact factor: 8.317

Review 6.  Respiratory medicine.

Authors:  R M du Bois
Journal:  BMJ       Date:  1995-06-17

7.  Differences in radiological/HRCT findings in eosinophilic bronchitis and asthma: implication for bronchial responsiveness.

Authors:  S-W Park; J-S Park; Y-M Lee; J-H Lee; A-S Jang; D-J Kim; Y Hwangbo; S-T Uh; Y-H Kim; C-S Park
Journal:  Thorax       Date:  2005-10-21       Impact factor: 9.139

8.  Impact of different etiologies of bronchiectasis on the pulmonary function tests.

Authors:  Agnaldo José Lopes; Gustavo Bittencourt Camilo; Sara Lucia Silveira de Menezes; Fernando Silva Guimarães
Journal:  Clin Med Res       Date:  2014-11-07

9.  HRCT score in bronchiectasis: correlation with pulmonary function tests and pulmonary artery pressure.

Authors:  Abdullaziz H Alzeer
Journal:  Ann Thorac Med       Date:  2008-07       Impact factor: 2.219

10.  Relationships between high-resolution computed tomography, lung function and bacteriology in stable bronchiectasis.

Authors:  Jin-Hwa Lee; Yoo-Kyung Kim; Hyon-Ju Kwag; Jung-Hyun Chang
Journal:  J Korean Med Sci       Date:  2004-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.